OncoCyte Corp
(NAS:OCX)
$
3.03
-0.03 (-0.98%)
Market Cap: 40.49 Mil
Enterprise Value: 38.25 Mil
PE Ratio: 0
PB Ratio: 2.16
GF Score: 32/100 OncoCyte Corp (OCX) Transcripts
- Q1 2024 OncoCyte Corp Earnings Call TranscriptMay 15, 2024$2.95 (+1.72%)Earnings
- Q4 2023 OncoCyte Corp Earnings Call TranscriptApr 12, 2024$2.71 (-8.60%)Earnings
- Q3 2023 OncoCyte Corp Earnings Call TranscriptNov 09, 2023$2.7 (+29.71%)Earnings
- Q2 2023 OncoCyte Corp Earnings Call TranscriptAug 10, 2023$3.51Earnings
- OncoCyte Corp Extraordinary Shareholders Meeting TranscriptJul 24, 2023
- OncoCyte Corp Annual Shareholders Meeting TranscriptJun 23, 2023
- Q1 2023 OncoCyte Corp Earnings Call TranscriptMay 11, 2023$5.46 (+2.40%)Earnings
- Q4 2022 OncoCyte Corp Earnings Call TranscriptApr 03, 2023$6.35 (-10.41%)Earnings
- Q3 2022 OncoCyte Corp Earnings Call TranscriptNov 10, 2022$12.01 (+0.05%)Earnings
- OncoCyte Corp at UBS Genomics 2.0 and MedTech Innovations Summit TranscriptAug 11, 2022
- Q2 2022 OncoCyte Corp Earnings Call TranscriptAug 10, 2022$19.02 (+10.57%)Earnings
- OncoCyte Corp DetermalO™ and Tumor Microenvironment in Clinical Practice Key Opinion Leader TranscriptJun 28, 2022
- Q1 2022 OncoCyte Corp Earnings Call TranscriptMay 11, 2022$22.6 (-2.59%)Earnings
- Q4 2021 OncoCyte Corp Earnings Call TranscriptMar 10, 2022$28 (+7.69%)Earnings
- OncoCyte Corp to Discuss Development and Co-Marketing Agreement with Thermo Fisher Scientific Inc Call TranscriptJan 18, 2022
- OncoCyte Corp Investor and Analyst Day TranscriptDec 14, 2021
- Q3 2021 OncoCyte Corp Earnings Call TranscriptNov 09, 2021$71.6 (+0.85%)Earnings
- OncoCyte Corp Key Opinion Leader Presentation Part 2: DetermaIO™ in Triple-Negative Breast Cancer TranscriptSep 28, 2021
- OncoCyte Corp Key Opinion Leader Presentation Part 1: Transplant Rejection Testing TranscriptSep 22, 2021
- Q2 2021 OncoCyte Corp Earnings Call TranscriptAug 10, 2021$100 (-1.96%)Earnings
- OncoCyte Corp Annual Shareholders Meeting TranscriptJun 24, 2021
- Q1 2021 OncoCyte Corp Earnings Call TranscriptMay 17, 2021$81.2 (+4.24%)Earnings
- OncoCyte Corp DetermaIO™ Data KOL Webinar TranscriptApr 19, 2021
- Q4 2020 OncoCyte Corp Earnings Call TranscriptMar 16, 2021$102.6 (+3.22%)Earnings
- Q3 2020 OncoCyte Corp Earnings Call TranscriptNov 12, 2020$33.6 (-4.00%)Earnings
- OncoCyte Corp - EGFR And Molecular Risk Stratification In Early-Stage NSCLC TranscriptOct 22, 2020
- OncoCyte Corporation - Special Call TranscriptAug 19, 2020
- Q2 2020 OncoCyte Corp Earnings Call TranscriptJul 29, 2020$27.4 (-4.20%)Earnings
- OncoCyte Corp Announces Completion Of Determadx™ Clinical Validation Study TranscriptJun 29, 2020
- OncoCyte Corp Annual Shareholders Meeting TranscriptJun 17, 2020
- Q1 2020 OncoCyte Corp Earnings Call TranscriptMay 12, 2020$54 (-6.57%)Earnings
- Q4 2019 OncoCyte Corp Earnings Call TranscriptMar 25, 2020$39.8 (-1.00%)Earnings
- OncoCyte Corp to Acquire Insight Genetics Inc - Conference Call TranscriptJan 10, 2020
- Q3 2019 OncoCyte Corp Earnings Call TranscriptNov 14, 2019$32.2 (-0.62%)Earnings
- Q2 2019 OncoCyte Corp Earnings Call TranscriptAug 14, 2019$41.8 (-7.93%)Earnings
- 1